Lutathera is a brand name for a radiopharmaceutical therapy used in the treatment of certain types of cancer, specifically neuroendocrine tumors (NETs) that express somatostatin receptors. It is a targeted therapy that combines a radioactive substance called lutetium-177 (Lu-177) with a molecule that binds to somatostatin receptors found on the surface of NET cells.

Here’s how Lutathera treatment works:

• Patient Preparation: Before receiving Lutathera therapy, patients typically undergo a diagnostic imaging procedure called a somatostatin receptor scintigraphy (SRS) or a positron emission tomography (PET) scan with a somatostatin analog radiotracer. This helps determine if their tumors express somatostatin receptors and are suitable for Lutathera treatment.

•  Administration: Lutathera consists of Lu-177 attached to a somatostatin analog, which is administered intravenously. The somatostatin analog helps target the radiation specifically to the cancer cells because these cells have a high concentration of somatostatin receptors.

• Targeted Radiation: Once Lutathera is injected into the bloodstream, it circulates in the body and binds to the somatostatin receptors on the surface of NET cells. The radioactive Lu-177 component emits beta radiation, which damages the cancer cells from within, while sparing surrounding healthy tissue to a significant extent.

• Therapeutic Effects: The radiation emitted by Lu-177 can kill or damage the NET cells, reducing the size of tumors and potentially slowing down the progression of the cancer. It can also help alleviate symptoms associated with NETs, such as hormonal overproduction.

• Follow-Up: After receiving Lutathera therapy, patients may undergo periodic imaging scans to monitor the response to treatment and assess the status of their tumors.

Lutathera therapy in gurgaon has been approved for the treatment of certain advanced or metastatic neuroendocrine tumors that express somatostatin receptors. It is considered a valuable treatment option for patients with these types of tumors when other treatments, such as surgery or conventional chemotherapy, may not be as effective.

It’s important to note that Lutathera therapy is administered in specialized medical centers by healthcare professionals with expertise in nuclear medicine and radiation oncology, and it is typically reserved for patients who meet specific criteria. The choice of treatment for a particular patient depends on their individual medical condition and needs, and decisions should be made in consultation with a healthcare provider.Discover the Leading Nuclear Medicine Radiology Services in Gurgaon

Dr. Dharmender Malik, a highly esteemed Consultant in Nuclear Medicine and PET CT at FMRI, Gurugram. And With an impressive professional background.Contact us 919625712300